DAILY UPDATE
June 7, 2021
Dear Valued Reader,

Turning the wheel over to Doc Gumshoe, for an update he sent to me a little while ago and that I've been late in posting for you -- he's got it all for you this time... thoughts on the CDC's mask recommendations, a couple Alzheimer's Disease drugs (coincidentally, on the day that the controversial aducanumab was approved), a fascinating microcap cancer story suggested by a reader -- what's not to like?  Just click below for Michael's latest...


Most options traders place high-risk trades, hoping for a big payout. But they lose... a LOT! Especially in today’s topsy-turvy market. That's why Jim Fink flips options trading on its head, making money more than 85% of the time. Now, he's offering to show his personal strategy guide to readers which could help you unlock as much as $67,548 in extra income.

Get your copy by clicking here now.


Advertisement

Miss anything in the wild world of Stock Gumshoe last week?  Let's catch you up...

The most-requested story was our solution to another "Alzheimer's Cure" tease -- this time Ray Blanco pitching a treatment for "Plaque Magnets" that he thinks will make us rich... what's the stock?  Just click here for that story.

And IPOs and Pre-IPOs continue to be hugely appealing to investors, which means that the newsletters keep pitching those ideas... and you keep asking yours truly for answers.  Happy to oblige... this time, it's Andy Snyder teasing his "#1 Pre-IPO Investment" for this year in ads for his Venture Fortunes... my take, and the Thinkolator answers?  Just a click away.

And in last week's Friday File for the Irregulars I jumped right in to one of my favorite asset classes, royalty companies, including a number of updated thoughts and two new buys in this space (as well as a couple add-on purchases)... details below...



Stock Gumshoe | travis@stockgumshoe.com | www.stockgumshoe.com
351 Pleasant St., Suite B #205, Northampton, MA 01060
Disclaimer: Nothing in this email or in the linked articles should be considered to be individual investment advice -- we can't tell you what you should do with your money, we can just share our opinions and perspective. Our authors try to use reliable information sources but also make mistakes of both fact and judgement on occasion, so all assertions should be checked and confirmed. You should speak with your financial advisor and understand everything fully before committing money to any investment.

Most issues of this email newsletter include advertising, and it should not be assumed that the presence of an advertisement means that the product or service advertised is endorsed by Stock Gumshoe or the author. For full disclaimers, disclosure information, and privacy policies please see the prominent links at the bottom of each page at StockGumshoe.com.

Having trouble viewing this email? Read the web version.

You may unsubscribe if you no longer wish to receive our emails. We have no wish to email people who don't want to receive these messages. Please note that unsubscribing applies only to receiving emails, if you are a member of the Stock Gumshoe Irregulars that membership will not automatically change or be canceled. Please contact us if you need to change a paid membership.